% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 124

Loading Chart...

6 inventors (with patents filed for the assignee):

Jörg Kaufmann (4 out of 33 patents)

Elena Feinstein (3 out of 74 patents)

Klaus Giese (2 out of 28 patents)

4. Oliver Keil (2 out of 14 patents)

5. Ansgar Santel (1 out of 9 patents)

6. Rami Skaliter (1 out of 12 patents)

7. Joerg Kaufmann (0 patent)

8. Jörg c/o Atugen Ag Kaufmann (0 patent)

9. Anke Klippel (0 patent)

5 patents: Sort by Forward Citations

1. 8232256 - Means for inhibiting the expression of protein kinase 3 (2012-07-31),

2. 8168607 - Methods of treating eye diseases in diabetic patients (2012-05-01),

3. 8067570 - Therapeutic uses of inhibitors of RTP801 (2011-11-29),

4. 8017804 - Lipids, lipid complexes and use thereof (2011-09-13),

5. 7741299 - Therapeutic uses of inhibitors of RTP801 (2010-06-22),

Company Overview

Silence Therapeutics Ag is a leading RNAi therapeutics company developing a new generation of medicines to treat diseases with significant unmet medical need. The company is focused on harnessing the body's natural mechanisms to inhibit or 'silence' the expression of disease-causing genes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#179 in Berlin

#6,102 in Germany

Berlin, Germany

Silence Therapeutics Ag

Forward Citations = 124

6 inventors:

Jörg Kaufmann (4 out of 33 patents)

Elena Feinstein (3 out of 74 patents)

Klaus Giese (2 out of 28 patents)

4. Oliver Keil (2 out of 14 patents)

5. Ansgar Santel (1 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Silence Therapeutics Ag. Retrieved from https://idiyas.com/company/silence-therapeutics-ag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]